Martin Shkreli’s Latest Plan to Sharply Raise Drug Price Prompts Outcry
Saturday, December 12, 2015 - 09:30
in Mathematics & Economics
Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients’ reach.